Clinical trial · Observational
New Biomarkers Evaluating Ovarian Cancer
Evaluation of New Biomarker Assays in Ovarian Cancer Patients Presenting to a Generalist With an Adnexal Mass
NCT01466049CI-TRIAL-00015320completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adnexal Mass | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evaluate novel biomarkers for patients with an adnexal mass
- timeFrame
- observational studies
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female, age 18 years or older * Adnexal mass present documented by imaging * Scheduled to undergo surgery based on a finding of adnexal mass * Able and willing to provide Informed Consent Exclusion Criteria: * Previous history of ovarian cancer * Previous history of bilateral oophorectomy * Currently known to be pregnant * Unable to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.